The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma (Q34500544)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma |
scientific article |
Statements
The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma (English)
Andrew Spencer
Sung-Soo Yoon
Shannon R Morris
Deborah A Smith
Richard A Brigandi
Jennifer Gauvin
Rakesh Kumar
Joanna B Opalinska
1 reference